These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1379004)

  • 21. Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lung.
    Terashita Z; Stahl GL; Lefer AM
    Biochem Pharmacol; 1988 Jul; 37(13):2659-65. PubMed ID: 2839198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An analysis of responses to levosimendan in the pulmonary vascular bed of the cat.
    De Witt BJ; Ibrahim IN; Bayer E; Fields AM; Richards TA; Banister RE; Kaye AD
    Anesth Analg; 2002 Jun; 94(6):1427-33, table of contents. PubMed ID: 12032000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of responses to leukotriene D4 in the pulmonary vascular bed.
    Kadowitz PJ; Hyman AL
    Circ Res; 1984 Nov; 55(5):707-17. PubMed ID: 6435907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-NAME enhances responses to atrial natriuretic peptide in the pulmonary vascular bed of the cat.
    Hyman AL; De Witt BJ; Gumusel B; Hao Q; Kadowitz PJ; Lippton HL
    J Appl Physiol (1985); 2001 Jun; 90(6):2101-8. PubMed ID: 11356772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of responses to bradykinin: effects of Hoe-140 in the hindquarters vascular bed of the cat.
    Santiago JA; Garrison EA; Kadowitz PJ
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H828-36. PubMed ID: 8067439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular effects of platelet-activating factor in lambs: role of cyclo- and lipoxygenase.
    Toga H; Hibler S; Ibe BO; Raj JU
    J Appl Physiol (1985); 1992 Dec; 73(6):2559-66. PubMed ID: 1490969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.
    Erdemli O; Hao Q; Cai B; Lippton HL; Hyman A
    Arch Int Pharmacodyn Ther; 1994; 328(2):165-79. PubMed ID: 7535994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of bronchoconstrictor responses to platelet-activating factor in the cat.
    Underwood DC; Kadowitz PJ
    J Appl Physiol (1985); 1989 Jul; 67(1):377-82. PubMed ID: 2759966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal pulmonary vasodilation after exogenous platelet-activating factor.
    Accurso FJ; Abman SH; Wilkening RB; Worthen GS; Henson P
    J Appl Physiol (1985); 1991 Feb; 70(2):778-87. PubMed ID: 2022570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daltroban blocks thromboxane responses in the pulmonary vascular bed of the cat.
    Hood JS; Nossaman BD; Ibrahim IN; McMahon TJ; Babycos CR; Kadowitz PJ
    J Appl Physiol (1985); 1992 Jun; 72(6):2305-10. PubMed ID: 1385804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of vasodilator responses to peroxynitrite in the hindlimb vascular bed of the cat.
    Nossaman BD; Bivalacqua TJ; Champion HC; Baber SR; Kadowitz PJ
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):358-66. PubMed ID: 18049302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Analysis of Responses to Defibrotide in the Pulmonary Vascular Bed of the Cat.
    Kaye AD; Skonieczny BD; Kaye AJ; Harris ZI; Luk EJ
    Am J Ther; 2016; 23(3):e757-65. PubMed ID: 24368612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-activating factor induces selective pulmonary arterial hyperreactivity in isolated perfused rabbit lungs.
    Ohar JA; Waller KS; Dahms TE
    Am Rev Respir Dis; 1993 Jul; 148(1):158-63. PubMed ID: 8317792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of thromboxane B2 on the canine and feline pulmonary vascular bed.
    Kadowitz PJ; Hyman AL
    J Pharmacol Exp Ther; 1980 May; 213(2):300-5. PubMed ID: 7365689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction.
    McCormack DG; Barnes PJ; Evans TW
    Crit Care Med; 1990 Dec; 18(12):1398-402. PubMed ID: 2245615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary vasodilator responses to nicardipine: comparison with other vasodilators.
    Matot I; Neely CF
    Crit Care Med; 1995 Nov; 23(11):1851-7. PubMed ID: 7587261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary vasodilator responses to vagal stimulation and acetylcholine in the cat.
    Nandiwada PA; Hyman AL; Kadowitz PJ
    Circ Res; 1983 Jul; 53(1):86-95. PubMed ID: 6407775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of thromboxane/endoperoxide receptor-mediated responses in the pulmonary vascular bed of the cat by sulotroban.
    Nossaman BD; McMahon TJ; Ragheb MS; Ibrahim IN; Babycos CR; Hood JS; Kadowitz PJ
    Eur J Pharmacol; 1992 Mar; 213(1):1-7. PubMed ID: 1379928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of responses to bradykinin in the pulmonary vascular bed of the cat.
    DeWitt BJ; Cheng DY; McMahon TJ; Nossaman BD; Kadowitz PJ
    Am J Physiol; 1994 Jun; 266(6 Pt 2):H2256-67. PubMed ID: 7517646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine does not mediate the pulmonary vasodilator response of adenosine 5'-triphosphate in the feline pulmonary vascular bed.
    Neely CF; Kadowitz PJ; Lippton H; Neiman M; Hyman AL
    J Pharmacol Exp Ther; 1989 Jul; 250(1):170-6. PubMed ID: 2501475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.